Arcadia Biosciences, Inc. short interest in 2022
In 2022, Arcadia Biosciences, Inc.'s disclosed short interest ran from 5.18% of shares outstanding on 14 Jan 2022 to 1.12% on 15 Dec 2022, a change of -4.06 percentage points. The year's high was 5.69% on 31 Mar 2022 and its low 1.12% on 15 Dec 2022, averaging 2.87% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.32 days on 15 Jul 2022. Full history: Arcadia Biosciences, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 5.18% (14 Jan 2022)
- End of year
- 1.12% (15 Dec 2022)
- Change
- -4.06 pp
- High
- 5.69% (31 Mar 2022)
- Low
- 1.12% (15 Dec 2022)
- Average
- 2.87%
- Highest days to cover
- 7.32 (15 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 5.18% | 1.00 | |
| 31 Jan 2022 | 4.70% | 1.45 | |
| 15 Feb 2022 | 4.31% | 2.30 | |
| 28 Feb 2022 | 3.32% | 3.71 | |
| 31 Mar 2022 | 5.69% | 1.00 | results (8-K), 10-K filed |
| 14 Apr 2022 | 4.58% | 1.25 | |
| 29 Apr 2022 | 3.43% | 1.84 | |
| 13 May 2022 | 2.93% | 1.82 | 10-Q filed, results (8-K) |
| 31 May 2022 | 3.21% | 1.00 | |
| 15 Jun 2022 | 2.67% | 1.92 | |
| 30 Jun 2022 | 1.88% | 1.93 | |
| 15 Jul 2022 | 2.13% | 7.32 | |
| 29 Jul 2022 | 2.09% | 5.27 | |
| 15 Aug 2022 | 2.39% | 4.42 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 2.15% | 1.98 | |
| 15 Sep 2022 | 1.89% | 3.27 | |
| 30 Sep 2022 | 1.84% | 1.91 | |
| 14 Oct 2022 | 1.71% | 3.29 | |
| 31 Oct 2022 | 1.53% | 1.09 | |
| 15 Nov 2022 | 2.53% | 2.73 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 1.80% | 4.16 | |
| 15 Dec 2022 | 1.12% | 1.64 |
See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.